Press release
Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments | Oragenics, Inc, Winclove Probiotics
Probiotics are live microorganisms that produces beneficial effects in human gut. Probiotics can be taken as a dietary supplement. They prevent diarrhoea and help to reduce the symptoms of irritable bowel syndrome.Download the sample report at: https://www.pharmaproff.com/request-sample/1189
Probiotics comprise of a variety of microorganisms belonging to the Lactobacillus and Bifidobacterium groups. The only yeast probiotic that has proven to be effective is Saccharomyces boulardii. According to researchers, probiotics are effective in treatment of digestive disorders, allergic disorders, oral disorders, colic, common cold, and liver diseases. Lactobacillus plantarum W1 is a probiotic that reduces the excess cholesterol levels, stimulate TH1 cells, and restore the intestinal permeability of human gut.
Get the detailed analysis at: https://www.pharmaproff.com/report/probiotics-therapeutics
Swecure AB is developing probiotics for the treatment of allergic disorders. Oragenics Inc. and Intrexon Corporation are developing ActoBiotic for the treatment of oral diseases. Some of the companies having probiotics pipeline are NutraHelix Biotech Pvt Ltd. and Winclove Probiotics B.V.
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Probiotics Therapeutics -Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments | Oragenics, Inc, Winclove Probiotics here
News-ID: 1812710 • Views: …
More Releases from Pharma Proff
Interleukin-6 (IL-6) Inhibitors Analysis, Clinical Trails and Developments
Interleukin-6 (IL-6) inhibitors currently exhibit a proliferating pipeline with 25+ therapeutic candidates.
IL-6 is a cytokine encoded by IL-6 gene, which helps in the maturation of B cells and is actively involved in the inflammatory response. The IL-6 protein is primarily produced at the sites of acute and chronic inflammation, where it is secreted into the serum and brings a transcriptional inflammatory response through IL-6? receptor. This protein is assumed to…
Retinitis Pigmentosa Therapeutics Analysis, Clinical Trials and Other Developmen …
Retinitis pigmentosa therapeutics currently exhibits a proliferating pipeline with 25+ therapeutic candidates.
Retinitis pigmentosa (RP) is a group of hereditary disorders that lead to the breakdown and loss of cells in the retina. Mutation in genes encoding the proteins required by retinal cells for their proper functioning, results in occurrence of RP. The disease results in partial vision loss during the earlier stage of the disease, which may lead to complete…
Niemann-Pick Disease Type C (NPC) Therapeutics Pipeline to Witness Significant G …
Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport cholesterol and lipids inside the cells. This causes accumulation of these substances within various tissues of the body. These substances…
Hepatorenal Syndrome Therapeutics Pipeline Analysis 2018, Clinical Trials & Resu …
Hepatorenal syndrome (HRS) is a reversible functional renal impairment, that occurs in patients with advanced liver cirrhosis or those with fulminant hepatic failure. It is characterized by a marked reduction in glomerular filtration rate and renal plasma flow, in the absence of other causes of renal failure.
Download the sample report at: https://www.pharmaproff.com/request-sample/1030
The symptoms of hepatorenal syndrome are fatigue, abdominal pain, malaise, ascites, jaundice, splenomegaly, and hepatomegaly. There are two…
More Releases for Probiotics
OptiBac Probiotics Market Is Booming Worldwide 2025-2032 | OptiBac Probiotics, N …
Global OptiBac Probiotics Market is estimated to be valued at USD 0.30 Bn in 2025 and is expected to reach USD 0.49 Bn by 2032, growing at a CAGR of 7.1% from 2025 to 2032.
According to the latest research from Coherent Market Insights, the OptiBac Probiotics Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough research, highlighting current…
Next Generation Probiotics Market to Witness Remarkable Growth with Pendulum, Am …
The latest Research report published by Coherent Market Insights with the title "An Increase in Demand and Opportunities for Global Next Generation Probiotics Market 2025" provides a sorted image of the Next Generation Probiotics Market industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making an ongoing impact on the…
Next Generation Probiotics Market Projected To Witness Substantial Growth, 2025- …
🚀 Next Generation Probiotics Market to grow at a CAGR of 11.2% (2025 - 2032)
The Next Generation Probiotics Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
» 70% efforts of Primary Research
» 15% efforts of Secondary Research
» 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies
📈 𝐚𝐬…
Global Pet probiotics market
The Pet Probiotics market accounted for USD 848.6 Million in 2024 and is expected to reach USD 2,156.8 Million by 2035, growing at a CAGR of around 8.85% between 2025 and 2035. The pet probiotics market provides supplementary products that aim at enhancing the gut health of pets, digestion, and immunity. Increasing pet ownership and growing awareness of animal welfare are two aspects driving demand in this industry. Probiotics are…
Probiotics Dietary Supplements Market Is Driven By Probiotics Dietary Supplement …
The probiotics dietary supplements market is a rapidly growing segment of the broader dietary supplements industry, driven by the increasing awareness of the importance of gut health and the numerous health benefits associated with probiotics. Probiotics are live microorganisms, typically beneficial bacteria like lactobacillus and bifidobacterium, that can provide a wide range of health advantages when consumed in adequate amounts. These benefits include improved digestive health, enhanced immune function, and…
Next Generation Probiotics Market Next Big Thing | Major Giants Winclove Probiot …
Advance Market Analytics published a new research publication on "Next Generation Probiotics Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Next Generation Probiotics market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
